1290053-80-3

Upstream product

• 286961-24-8 benzyl 1,2,3,6-tetrahydro-4-(trifluoromethylsulphonyloxy)-pyridine-1-carboxylate 
• 1290056-69-7 tert-butyl 3-(1-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthoyl)piperidin-4-yl)benzylcarbamate 
• 150255-96-2 (3‐cyanophenyl)boronic acid 
• 6952-59-6 3-cyanobromobenzene 
• 919363-25-0 6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-naphthalene-1-carboxylic acid methyl ester 
• 1290056-68-6 6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-naphthalene-1-carboxylic acid 
• 725228-49-9 tert-butyl 3-(piperidin-4-yl)benzylcarbamate 
• 19099-93-5 benzyl 4-oxo-1-piperidinecarboxylate 

Relevant academic research and scientific papers

COFERONS AND METHODS OF MAKING AND USING THEM

The present invention is directed to a monomer useful in preparing therapeutic compounds. The monomer includes one or more pharmacophores which potentially binds to a target molecule with a dissociation constant of less than 300 μM and a linker element connected to the pharmacophore. The linker element has a molecular weight less than 500 daltons, is connected, directly or indirectly through a connector, to the pharmacophore.